Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 564.50, up by 14.80 points or 2.69% from its previous closing of Rs. 549.70 on the BSE.

The scrip opened at Rs. 552.00 and has touched a high and low of Rs. 567.30 and Rs. 552.00 respectively. So far 1,34,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 854.50 on 04-Aug-2016 and a 52 week low of Rs. 493.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 567.30 and Rs. 543.50 respectively. The current market cap of the company is Rs. 1,35,569.00 crore.

The promoters holding in the company stood at 54.39%, while Institutions and Non-Institutions held 33.49% and 12.13% respectively.

Sun Pharmaceutical Industries and one of its wholly-owned subsidiaries (collectively Sun Pharma) have entered into settlements with certain plaintiffs in re Modafinil Antitrust Litigation matter currently pending in the United States District Court for the Eastern District of Pennsylvania.

The settlements extend to all claims brought by Apotex Corporation and the Retailer Purchaser Plaintiffs. The settlements remain subject to the execution of definitive documentation and the terms of the settlement are confidential.

Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.